Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Stroke & Vascular Excellence Forum

Stroke & Vascular
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Conference Coverage
ESOC 2022: Trial and Research Reviews
05/23/2022
Amrou Sarraj, MD, highlights the RACECAT and PEACH trials as well as showcases information regarding the benefits of flying intervention teams and intraventricular fibrinolysis.
Amrou Sarraj, MD, highlights the RACECAT and PEACH trials as well as showcases information regarding the benefits of flying intervention teams and intraventricular fibrinolysis.
Amrou Sarraj, MD, highlights the...
05/23/2022
Neurology
Expert Conversations
Podcasts
An Overview of Mission Thrombectomy 2020+
05/14/2022
Amrou Sarraj, MD, interviews Dileep R Yavagal, MD, about the efforts of Mission Thrombectomy 2020+ and their efforts to implement 202,000 thrombectomies globally.
Amrou Sarraj, MD, interviews Dileep R Yavagal, MD, about the efforts of Mission Thrombectomy 2020+ and their efforts to implement 202,000 thrombectomies globally.
Amrou Sarraj, MD, interviews...
05/14/2022
Neurology
Stroke_Experts
Podcasts
Discussing BEST-MSU Trial Results: Improving Clinical Outcomes with Mobile Stroke Units
04/21/2022
Amrou Sarraj, MD, interviews James Grotta, MD, regarding the benefit of prehospital stroke treatment delivered through a mobile stroke unit.
Amrou Sarraj, MD, interviews James Grotta, MD, regarding the benefit of prehospital stroke treatment delivered through a mobile stroke unit.
Amrou Sarraj, MD, interviews...
04/21/2022
Neurology
Expert Conversations Pod
Podcasts
Expert Conversations: The Future of the Mobile Stroke Unit
06/17/2021
In part three of this series on mobile stroke units, Section Editor Amrou Sarraj MD, discusses the future with experts James Grotta MD, Geoffrey Donnan AO, and Stephen Davis AM. Topics include upcoming integration with clinical practices,...
In part three of this series on mobile stroke units, Section Editor Amrou Sarraj MD, discusses the future with experts James Grotta MD, Geoffrey Donnan AO, and Stephen Davis AM. Topics include upcoming integration with clinical practices,...
In part three of this series on...
06/17/2021
Neurology
Expert Conversations: Advances of the Mobile Stroke Unit
Podcasts
Expert Conversations: Advances of the Mobile Stroke Unit
05/28/2021
In the second installment of this podcast, international experts in stroke medicine sat down with Neurology Learning Network’s Section Editor Amrou Sarraj, MD, to discuss the clinical implications, advances, and future possibilities for...
In the second installment of this podcast, international experts in stroke medicine sat down with Neurology Learning Network’s Section Editor Amrou Sarraj, MD, to discuss the clinical implications, advances, and future possibilities for...
In the second installment of...
05/28/2021
Neurology
Podcasts
Expert Conversations: Evolution of Mobile Stroke Units and Pre-Hospital Care
05/25/2021
In part one of this series, Section Editor Amrou Sarraj, MD, discusses the core concepts of mobile stroke units as well as findings from recent clinical trials with James Grotta, MD, Director of Stroke Research, Clinical Institute for...
In part one of this series, Section Editor Amrou Sarraj, MD, discusses the core concepts of mobile stroke units as well as findings from recent clinical trials with James Grotta, MD, Director of Stroke Research, Clinical Institute for...
In part one of this series,...
05/25/2021
Neurology
Expert Conversations: Evolution of Mobile Stroke Units and Pre-Hospital Care
Expert Conversations: Evolution of Mobile Stroke Units and Pre-Hospital Care
05/25/2021
In part one of this series, Section Editor Amrou Sarraj, MD, discusses the core concepts of mobile stroke units as well as findings from recent clinical trials with James Grotta, MD, Director of Stroke Research, Clinical Institute for...
In part one of this series, Section Editor Amrou Sarraj, MD, discusses the core concepts of mobile stroke units as well as findings from recent clinical trials with James Grotta, MD, Director of Stroke Research, Clinical Institute for...
In part one of this series,...
05/25/2021
Neurology
Expert Conversations: Neuroprotection for Acute Ischemic Stroke
Podcasts
Expert Conversations: Neuroprotection for Acute Ischemic Stroke
04/23/2021
In this podcast, Neurology Learning Network’s Stroke & Vascular Section Editor Amrou Sarraj, MD, interviews Michael Hill, MD, FAHA, FCAHS, FESO, FRCPC, University of Calgary, on the past, present, and future of neuroprotection treatments for...
In this podcast, Neurology Learning Network’s Stroke & Vascular Section Editor Amrou Sarraj, MD, interviews Michael Hill, MD, FAHA, FCAHS, FESO, FRCPC, University of Calgary, on the past, present, and future of neuroprotection treatments for...
In this podcast, Neurology...
04/23/2021
Neurology
Expert Conversations: A Review of Data for Thrombolysis
Podcasts
Expert Conversations: A Review of Data for Thrombolysis
03/15/2021
In this podcast, Neurology Learning Network’s Stroke & Vascular Section Editor Amrou Sarraj, MD, interviews Professor Bruce Campbell, MBBS(Hons), BMedSc, PhD, about data for thrombolysis. They discuss a historic perspective on thrombolytic...
In this podcast, Neurology Learning Network’s Stroke & Vascular Section Editor Amrou Sarraj, MD, interviews Professor Bruce Campbell, MBBS(Hons), BMedSc, PhD, about data for thrombolysis. They discuss a historic perspective on thrombolytic...
In this podcast, Neurology...
03/15/2021
Neurology
Stroke Medicine: What`s on the Horizon for 2021?
Podcasts
Stroke Medicine: What`s on the Horizon for 2021?
02/19/2021
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, discusses anticipated developments this year in the areas of thrombolysis, thrombectomy, neuroprotection, stroke prevention, and more.
In this podcast, Neurology Learning Network's Stroke & Vascular Section Editor Amrou Sarraj, MD, discusses anticipated developments this year in the areas of thrombolysis, thrombectomy, neuroprotection, stroke prevention, and more.
In this podcast, Neurology...
02/19/2021
Neurology

Advertisement

Advertisement

News

News
5 Questions on the Optimization of Patient Selection for Endovascular Therapy in AIS
04/07/2020
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in...
Neurology Consultant spoke with the SELECT trial national principal investigator and lead author Amrou Sarraj, MD, whose trial shed light on how the use of imaging modalities can be optimized following the onset of acute ischemic stroke in...
Neurology Consultant spoke with...
04/07/2020
Neurology
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
News
Fremanezumab Shows Positive Results for Pediatric Use in Phase 3 Trial
08/08/2024
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive results in a phase 3 trial of migraine medication Ajovy (fremanezumab) for children and adolescents, making it the first anti-CGRP (calcitonin gene-related peptide) monoclonal antibody to be effective in this...
In July, Teva announced positive...
08/08/2024
Neurology
brain waves
News
High-Dose Statins May Not Benefit Patients With Mild Ischemic Stroke
08/08/2024
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose therapy, high-dose statin therapy in patients with mild ischemic stroke did not decrease the risk of stroke recurrence and was associated with an increased risk of intracranial hemorrhage over 12 months.
Compared with moderate-dose...
08/08/2024
Neurology
An illustration of a healthcare provider conducting a telehealth appointment
News
Teleneurology Visits Acceptable to Patients Across Neurologic Conditions
08/05/2024
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic condition, patients rated outpatient teleneurology appointments as highly acceptable, according to a study published in the Journal of Neurology.
Regardless of their neurologic...
08/05/2024
Neurology
The US Food and Drug Administration headquarters sign.
News
DMD Gene Therapy Indication Expanded to Include Boys 4 and Older
08/01/2024
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an indication expansion for the gene therapy Elevidys (delandistrogene moxeparvovec-rokl) to include patients with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who are nonambulatory and 4...
The US FDA approved an...
08/01/2024
Neurology
A person walks down a boarded path with sunlight and trees in the background
News
Backward Walking Speed Reserve Reflects Disease Severity in Patients With MS
07/30/2024
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve, or the difference between an individual’s preferred and maximal backward walking speed, was associated with disease severity in patients with multiple sclerosis (MS).
Backward walking speed reserve,...
07/30/2024
Neurology
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
News
FDA Approves Efgartigimod Alfa/Hyaluronidase for CIDP Treatment
07/29/2024
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod alfa/hyaluronidase) was recently approved by the Food and Drug Administration (FDA) for the treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP). 
VYVGART Hytrulo (efgartigimod...
07/29/2024
Neurology
A middle-aged male running
News
Moderate Physical Activity May Mitigate ALS Risk for Male Patients
07/25/2024
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in moderate physical activity and fitness may lower their risk for amyotrophic lateral sclerosis (ALS) later in life, according to study findings published in Neurology.
Male individuals who engage in...
07/25/2024
Neurology
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
News
Pitolisant Receives FDA Approval for Pediatric Patients With Narcolepsy
07/23/2024
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug Administration (FDA) recently approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness in pediatric patients 6 years and older with narcolepsy, US maker Harmony Biosciences announced.
The US Food and Drug...
07/23/2024
Neurology
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
News
Chronic Loneliness Associated With Hiked Stroke Risk in Older Adults
07/22/2024
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was associated with higher stroke risk, independent of other factors, according to recent prospective cohort study results published in eClinicalMedicine. 
Chronic loneliness was...
07/22/2024
Neurology
a hand breaks a wooden human figurine in half
News
Atogepant Reduces Migraine Days in Patients With Pain Medication Overuse
07/18/2024
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related peptide inhibitor atogepant reduced monthly migraine and headache days, as well as days using pain medication, in patients with chronic migraine with and without acute medication overuse.
The calcitonin gene-related...
07/18/2024
Neurology

Advertisement

Advertisement

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement